KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Gains from Investment Securities (2019 - 2025)

Historic Gains from Investment Securities for Boston Scientific (BSX) over the last 9 years, with Q4 2025 value amounting to $63.0 million.

  • Boston Scientific's Gains from Investment Securities fell 3505.15% to $63.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $105.0 million, marking a year-over-year increase of 396.04%. This contributed to the annual value of $258.0 million for FY2025, which is 11147.54% up from last year.
  • Per Boston Scientific's latest filing, its Gains from Investment Securities stood at $63.0 million for Q4 2025, which was down 3505.15% from $11.0 million recorded in Q3 2025.
  • Boston Scientific's Gains from Investment Securities' 5-year high stood at $97.0 million during Q4 2024, with a 5-year trough of -$138.0 million in Q4 2022.
  • In the last 5 years, Boston Scientific's Gains from Investment Securities had a median value of $11.5 million in 2023 and averaged $550000.0.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first crashed by 105000.0% in 2021, then soared by 54666.67% in 2024.
  • Boston Scientific's Gains from Investment Securities (Quarter) stood at -$19.0 million in 2021, then plummeted by 626.32% to -$138.0 million in 2022, then surged by 110.87% to $15.0 million in 2023, then soared by 546.67% to $97.0 million in 2024, then plummeted by 35.05% to $63.0 million in 2025.
  • Its Gains from Investment Securities stands at $63.0 million for Q4 2025, versus $11.0 million for Q3 2025 and -$5.0 million for Q2 2025.